Bellato, Renelen .

HRN: 15-64-54  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2025
CEFUROXIME 500MG (TAB)
04/26/2025
05/03/2025
ORAL
500mg
BID
S/P NSD; Thickly MSAF
Waiting Final Action 
04/26/2025
METRONIDAZOLE 500MG (TAB)
04/26/2025
05/03/2025
ORAL
500mg
TID
S/P NSD; Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: